A Systematic Review of Systemic Treatment Options for Advanced Non-Clear Cell Renal Cell Carcinoma
Author:
Affiliation:
1. Division of Hematology/Oncology, University of North Carolina, Chapel Hill, NC, USA
2. Division of Hematology/Oncology, Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA
Publisher
IOS Press
Subject
Nephrology,Oncology
Reference47 articles.
1. Localized non-conventional renal cell carcinoma: Prediction of clinical outcome according to histology;Kim;Int J Urol,2014
2. Comprehensive Analysis of Survival Outcomes in Non–Clear Cell Renal Cell Carcinoma Patients Treated in Clinical Trials;de Velasco;Clin Genitourin Cancer,2017
3. Siegel RL , Miller KD , Jemal A . Cancer statistics, 2016. - PubMed - NCBI. CA Cancer J Clin [Internet]. 2016 [cited 2019 Aug 25];66(1):7–30. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26742998
4. Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma;Rini;N Engl J Med [Internet],2019
5. Avelumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma;Motzer;N Engl J Med,2019
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. FDG-Avid Metastatic Non–Clear Cell Renal Cell Carcinoma Presenting as Intussusception;Clinical Nuclear Medicine;2024-06-27
2. Advanced renal cell carcinoma management: the Latin American Cooperative Oncology Group (LACOG) and the Latin American Renal Cancer Group (LARCG) consensus update;Journal of Cancer Research and Clinical Oncology;2024-04-09
3. The genomic and transcriptomic landscape of advanced renal cell cancer for individualized treatment strategies;Scientific Reports;2023-07-03
4. Insulin receptor expression to predict resistance to axitinib and elucidation of the underlying molecular mechanism in metastatic renal cell carcinoma;British Journal of Cancer;2023-06-24
5. Renal Cell Carcinoma;Holland‐Frei Cancer Medicine;2022-10-21
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3